The profitability of Legence Corp. over the past 3 years
Chart Legence Corp.: gross profit, operating income, net income, fiscal 2023–2025 Open the chart →Legence Corp. reported a net loss of $59.78M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $535.92M and operating income of $61.58M. It reported a loss in all 3 years shown.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $535.92M | $61.58M | -$59.78M |
| 2024ended Dec 31, 2024 | $430.77M | $70.35M | -$28.55M |
| 2023ended Dec 31, 2023 | $315.15M | $10.26M | -$46.03M |
Fiscal years as Legence Corp. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Legence Corp.
- The revenue of Legence Corp.
- The cash flow of Legence Corp.
- All of Legence Corp.'s financials, charted
Companies of a similar size
- ELVNENLIVEN THERAPEUTICS, INC.
- BCCBoise Cascade Company
- NBTBNBT BANCORP INC
- WLYJOHN WILEY & SONS, INC.
- REZIResideo Technologies, Inc.
Not investment advice. This page shows what Legence Corp. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.